Advertisement

Management of patients with type 2 diabetes and multiple chronic conditions: A Delphi consensus of the Spanish Society of Internal Medicine

Published:November 13, 2015DOI:https://doi.org/10.1016/j.ejim.2015.10.015

      Abstract

      Aims

      To develop consensus-based recommendations for the management of chronic complex patients with type 2 diabetes mellitus using a two round Delphi technique.

      Methods

      Experts from the Diabetes and Obesity Working Group (DOWG) of the Spanish Society of Internal Medicine (SEMI) reviewed MEDLINE, PubMed, SCOPUS and Cochrane Library databases up to September 2014 to gather information on organization and health care management, stratification of therapeutic targets and therapeutic approach for glucose control in chronic complex patients with type 2 diabetes mellitus.
      A list of 6 recommendations was created and rated by a panel of 75 experts from the DOWG by email (first round) and by open discussion (second round). A written document was produced and sent back to DOWG experts for clarification purposes.

      Results

      A high degree of consensus was achieved for all recommendations summarized as 1) there is a need to redesign and test new health care programs for chronic complex patients with type 2 diabetes mellitus; 2) therapeutic targets in patients with short life expectancy should be individualized in accordance to their personal, clinical and social characteristics; 3) patients with chronic complex conditions and type 2 diabetes mellitus should be stratified by hypoglycemia risk; 4) age and specific comorbidities should guide the objectives for glucose control; 5) the risk of hypoglycemia should be a key factor when choosing a treatment; and 6) basal insulin analogs compared to human insulin are cost-effective options.

      Conclusion

      The assessment and recommendations provided herein represent our best professional judgment based on current data and clinical experience.

      Abbreviations:

      CCM (Chronic Care Model), CGW (Core Working Group), DOWG (Diabetes and Obesity Working Group), NPH (Neutral Protamine Hagedorn), SEMI (Spanish Society of Internal Medicine), T2DM (type 2 diabetes mellitus)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Soriguer F.
        • Goday A.
        • Bosch-Comas A.
        • Bordiú E.
        • Calle-Pascual A.
        • Carmena R.
        • et al.
        Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected] Study.
        Diabetologia. 2012; 55: 88-93https://doi.org/10.1007/s00125-011-2336-9
        • Eschwege E.
        • Basdevant A.
        • Crine A.
        • Moisan C.
        • Charles M.A.
        Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.
        Diabetes Metab. 2015; 41: 55-61https://doi.org/10.1016/j.diabet.2014.11.007
        • Alonso-Morán E.
        • Satylganova A.
        • Orueta J.F.
        • Nuño-Solinis R.
        Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.
        BMC Public Health. 2014; 14769https://doi.org/10.1186/1471-2458-14-769
        • Formiga F.
        • Ferrer A.
        • Padrós G.
        • Corbella X.
        • Cos L.
        • Sinclair A.J.
        • et al.
        Diabetes mellitus as a risk factor for functional and cognitive decline in very old people: the Octabaix study.
        J Am Med Dir Assoc. 2014; 15: 924-928https://doi.org/10.1016/j.jamda.2014.07.019
        • Thanopoulou A.
        • Pectasides D.
        Real life cancer comorbidity in Greek patients with diabetes mellitus followed up at a single diabetes center: an unappreciated new diabetes complication.
        J Diabetes Res. 2014; 2014231425https://doi.org/10.1155/2014/231425
        • Garín N.
        • Olaya B.
        • Perales J.
        • Moneta M.V.
        • Miret M.
        • Ayuso-Mateos J.L.
        • et al.
        Multimorbidity patterns in a national representative sample of the Spanish adult population.
        PLoS ONE. 2014; 9e84794https://doi.org/10.1371/journal.pone.0084794
        • American Diabetes Association
        Standards of medical care in diabetes—2015 abridged for primary care providers.
        Clin Diabetes. 2015; 33: 97-111https://doi.org/10.2337/diaclin.33.2.97
        • Boyd C.M.
        • Darer J.
        • Boult C.
        • Fried L.P.
        • Boult L.
        • Wu A.W.
        Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.
        JAMA. 2005; 294: 716-724https://doi.org/10.1001/jama.294.6.716
        • Bernabeu-Wittel M.
        • Alonso-Coello P.
        • Rico-Blázquez M.
        • Rotaeche Del Campo R.
        • Sánchez Gómez S.
        • Casariego Vales E.
        Development of clinical practice guidelines for patients with comorbidity and multiple diseases.
        Rev Clin Esp. 2014; 214: 328-335https://doi.org/10.1016/j.rce.2014.04.001
        • Linstone H.
        • Turoff M.
        The Delphi method. Techniques and application.
        Addison-Wesley Publishing Company, Sydney/Tokyo1975
        • Wagner E.H.
        • Austin B.T.
        • Von Korff M.
        Organizing care for patients with chronic illness.
        Milbank Q. 1996; 74: 511-544
        • Boult C.
        • Wieland G.D.
        Comprehensive primary care for older patients with multiple chronic conditions: “Nobody rushes you through”.
        JAMA. 2010; 304: 1936-1943https://doi.org/10.1001/jama.2010.1623
        • Coleman K.
        • Austin B.T.
        • Brach C.
        • Wagner E.H.
        Evidence on the Chronic Care Model in the new millennium.
        Health Aff (Millwood). 2009; 28: 75-85https://doi.org/10.1377/hlthaff.28.1.75
        • Mery G.
        • Wodchis W.
        Management of populations with multiple chronic conditions in Ontario: suggested components of standard care and performance measurement for shared accountability.
        Health System Performance Research Network (HSPRN). 2013 (Available from: http://www.hsprn.ca/uploads/files/HSPRN%20Multimorbid%20Populations%20%28Evidence%20Brief%20May%2012%202014%29%20April%202013.pdf.)
        • Smith S.M.
        • Soubhi H.
        • Fortin M.
        • Hudon C.
        • O'Dowd T.
        Managing patients with multimorbidity: systematic review of interventions in primary care and community settings.
        BMJ. 2012; (345e5205)https://doi.org/10.1136/bmj.e5205
        • Public Internal Control Systems in the European Union
        Continual organisational improvement by integrating internal control into the management cycle.
        in: Discussion Paper No. 2. 2014 (Available from: http://ec.europa.eu/budget/pic/lib/docs/pic_paper2_en.pdf.)
        • Durán Alonso J.C.
        Investigadores del estudio Diagerca. [Prevalence of diabetes mellitus in geriatric patients in nursing homes of Cadiz. Diagerca study].
        Rev Esp Geriatr Gerontol. 2012; 47: 114-118https://doi.org/10.1016/j.regg.2011.11.003
        • Araki A.
        • Ito H.
        Diabetes mellitus and geriatric syndromes.
        Geriatr Gerontol Int. 2009; 9: 105-114https://doi.org/10.1111/j.1447-0594.2008.00495.x
        • Sinclair A.
        • Morley J.E.
        • Rodríguez-Mañas L.
        • Paolisso G.
        • Bayer T.
        • Zeyfang A.
        • et al.
        Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes.
        J Am Med Dir Assoc. 2012; 13: 497-502https://doi.org/10.1016/j.jamda.2012.04.012
        • End of Life Diabetes Care
        Full strategy document.
        (october)Commissioned by Diabetes UK. 2nd ed. 2013 (Available from: https://www.diabetes.org.uk/Upload/Position%20statements/End-of-life-care_strategy_Doc111113.pdf.)
        • Formiga F.
        • Rodríguez Mañas L.
        Type 2 diabetes mellitus in the elderly, new evidence to apply the knowledge in daily clinical practice.
        Rev Esp Geriatr Gerontol. 2013; 48: 53-54https://doi.org/10.1016/j.regg.2012.11.002
        • Hager K.K.
        • Loprinzi P.
        • Stone D.
        Implementing diabetes care guidelines in long term care.
        J Am Med Dir Assoc. 2013; 14 (851 e): 7-15https://doi.org/10.1016/j.jamda.2013.05.020
        • American Diabetes Association
        Standards of medical care in diabetes—2009.
        Diabetes Care. 2009; 32: 13-61https://doi.org/10.2337/dc09-S013
        • Benetos A.
        • Novella J.L.
        • Guerci B.
        • Blickle J.F.
        • Boivin J.M.
        • Cuny P.
        • et al.
        Pragmatic diabetes management in nursing homes: individual care plan.
        J Am Med Dir Assoc. 2013; 14: 791-800https://doi.org/10.1016/j.jamda.2013.08.003
        • Bramlage P.
        • Gitt A.K.
        • Binz C.
        • Krekler M.
        • Deeg E.
        • Tschope D.
        Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia.
        Cardiovasc Diabetol. 2012; 11122https://doi.org/10.1186/1475-2840-11-122
        • Moghissi E.
        • Ismail-Beigi F.
        • Devine R.C.
        Hypoglycemia: minimizing its impact in type 2 diabetes.
        Endocr Pract. 2013; 19: 526-535https://doi.org/10.4158/EP13005.RA
        • de Vries N.M.
        • Staal J.B.
        • van Ravensberg C.D.
        • Hobbelen J.S.
        • Olde Rikkert M.G.
        • Nijhuis-van der Sanden M.W.
        Outcome instruments to measure frailty: a systematic review.
        Ageing Res Rev. 2011; 10: 104-114https://doi.org/10.1016/j.arr.2010.09.001
        • Pilotto A.
        • Ferrucci L.
        • Franceschi M.
        • D'Ambrosio L.P.
        • Scarcelli C.
        • Cascavilla L.
        • et al.
        Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients.
        Rejuvenation Res. 2008; 11: 151-161https://doi.org/10.1089/rej.2007.0569
        • Pilotto A.
        • Noale M.
        • Maggi S.
        • Addante F.
        • Tiengo A.
        • Perin P.C.
        • et al.
        Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients.
        Biomed Res Int. 2014; 2014906103https://doi.org/10.1155/2014/906103
        • Inzucchi S.E.
        • Bergenstal R.M.
        • Buse J.B.
        • Diamant M.
        • Ferrannini E.
        • Nauck M.
        • et al.
        Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
        Diabetes Care. 2012; 35: 1364-1379https://doi.org/10.2337/dc12-0413
        • Menéndez Torre E.
        • Lafita Tejedor F.J.
        • Artola Menéndez S.
        • Millán Núñez-Cortés J.
        • Alonso García A.
        • Puig Domingo M.
        • et al.
        Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes.
        Aten Primaria. 2011; 202: e1-e9https://doi.org/10.1016/j.aprim.2010.07.012
        • Ismail-Beigi F.
        • Moghissi E.
        • Tiktin M.
        • Hirsch I.B.
        • Inzucchi S.E.
        • Genuth S.
        Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.
        Ann Intern Med. 2011; 154: 554-559https://doi.org/10.7326/0003-4819-154-8-201104190-00007
        • Ismail-Beigi F.
        Clinical practice. Glycemic management of type 2 diabetes mellitus.
        N Engl J Med. 2012; 366: 1319-1327https://doi.org/10.1056/NEJMcp1013127
        • AmericanDiabetes Association
        Standards of medical care in diabetes—2014.
        Diabetes Care. 2014; 37: 14-80https://doi.org/10.2337/dc14-S014
        • Garber A.J.
        • Abrahamson M.J.
        • Barzilay J.I.
        • Blonde L.
        • Bloomgarden Z.T.
        • Bush M.A.
        • et al.
        American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement—executive summary.
        Endocr Pract. 2013; 19: 536-557https://doi.org/10.4158/EP13176.CS
        • International Diabetes Federation
        Managing older people with type 2 diabetes. Global guideline.
        (Available from)
        • Kirkman M.S.
        • Briscoe V.J.
        • Clark N.
        • Florez H.
        • Haas L.B.
        • Halter J.B.
        • et al.
        Diabetes in older adults.
        Diabetes Care. 2012; 35: 2650-2664https://doi.org/10.2337/dc12-1801
        • Sinclair A.J.
        • Paolisso G.
        • Castro M.
        • Bourdel-Marchasson I.
        • Gadsby R.
        • Rodríguez Mañas L.
        • et al.
        European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary.
        Diabetes Metab. 2011; 37: 27-38https://doi.org/10.1016/S1262-3636(11)70962-4
        • Gómez Huelgas R.
        • Díez-Espino J.
        • Formiga F.
        • Lafita Tejedor J.
        • Rodríguez Mañas L.
        • González-Sarmiento E.
        • et al.
        Treatment of type 2 diabetes in the elderly.
        Med Clin (Barc). 2013; 140 (134): e1-e12https://doi.org/10.1016/j.medcli.2012.10.003
        • Nordin C.
        The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
        Diabetologia. 2010; 53: 1552-1561https://doi.org/10.1007/s00125-010-1752-6
        • Grunberger G.
        Insulin analogs-are they worth it? Yes!.
        Diabetes Care. 2014; 37: 1767-1770https://doi.org/10.2337/dc14-0031
        • Cameron C.G.
        • Bennett H.A.
        Cost-effectiveness of insulin analogues for diabetes mellitus.
        CMAJ. 2009; 180: 400-407https://doi.org/10.1503/cmaj.081180
        • Davidson M.B.
        Insulin analogs—is there a compelling case to use them? No!.
        Diabetes Care. 2014; 37: 1771-1774https://doi.org/10.2337/dc13-2915
        • National Institute for Health and Clinical Excellence (NICE)
        Guidance on the use of long-acting insulin analogues for the treatment of diabetes—insulin glargine. NICE technology appraisal guidance 53.
        ([updated December 2014])
        • Rubio-Terrés C.
        • Rodríguez J.
        • Bolinder B.
        • de Pablos P.
        Cost utility analysis of the diabetes mellitus treatment with glargine insuline or nph insuline in Spain.
        Rev Esp Econ Salud. 2003; 2 ([Available from: http://healthvalue.org/pdfs/rees%202004.pdf.]): 313-324